Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 751–775 of 27,380 studies, newest first · page 31 of 1096.

August 2026 25

  1. 2026-08-14

    Diffusion kurtosis imaging (gen)omics unravels mechanisms of cerebral small vessel disease

    ⚠ Preprint — not yet peer-reviewed Biomarkers medRxiv (preprint)

    Key finding: We identified four genome-wide significant loci associated with DKI markers at chr3p25.1 (LINC00620-WNT7A), chr5q14.2 (VCAN), chr5q14.3 (VCAN-AS1) and chr8q24.21 (CCDC26), and 11 additional suggestive loci. +4 more findings

    Scored 23 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  2. 2026-08-14
  3. 2026-08-14

    Network connectivity and amyloid-β align with tau in atypical Alzheimer disease subtypes

    ✓ Peer-reviewed Brain scans and imaging Alzheimer s Research & Therapy

    Key finding: Converging evidence suggests that accumulation may be driven by spreading through network connections and/or interactions with amyloid-β (Aβ). +1 more finding

  4. 2026-08-14

    Chronic Disease and Disability in the United States: Trends, Inequities, and Imperatives for Policy Reform

    ✓ Peer-reviewed Risk factors Milbank Quarterly

    Key finding: In 2023, US life expectancy reached 78.5 years and healthy life expectancy 64.5 years, both still below prepandemic 2019 levels, with a persistent 13-14-year gap between life expectancy and healthy life expectancy. +4 more findings

  5. 2026-08-14

    A Phase 2b randomized clinical trial of the oral p38α inhibitor neflamapimod in dementia with Lewy bodies (DLB)

    ⚠ Preprint — not yet peer-reviewed Tau biomarkers Research Square

    Key finding: There is high unmet need in dementia with Lewy bodies (DLB). +3 more findings

    Scored 37 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  6. 2026-08-13

    Point Prevalence of Common Mental Health Conditions in Nigeria: A Systematic Review and Meta-Analysis

    ⚠ Preprint — not yet peer-reviewed How common it is Research Square

    Key finding: These estimates are planning values for populations resembling the contributing studies, not national population rates. +1 more finding

    Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  7. 2026-08-13

    Gut community-level analysis reveals an altered balance between Phocaeicola vulgatus and Bacteroides fragilis in Alzheimer’s disease

    ⚠ Preprint — not yet peer-reviewed Disease mechanisms bioRxiv

    Key finding: Our findings suggest that AD-associated gut microbiome variation extends beyond taxon-specific abundance to the balance between specific species within a community matrix.

    Scored 32 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  8. 2026-08-13

    High-frequency oscillations arise through distinct mechanisms in models of α- synucleinopathy and channelopathy-induced epilepsy

    ⚠ Preprint — not yet peer-reviewed Risk factors Research Square

    Key finding: Our findings indicate that HFOs likely arise from different neuronal populations and are generated through distinct mechanisms in these two models. +2 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  9. 2026-08-13

    Repurposing probucol for prevention of dementia: a nationwide cohort study

    ⚠ Preprint — not yet peer-reviewed Drug development Research Square

    Key finding: In this nationwide cohort, probucol use was associated with substantially lower dementia risk than statins, supporting evaluation of probucol for repurposing in dementia prevention. +1 more finding

    Scored 40 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  10. 2026-08-13

    The missing improvers: Tau pathology, neuroplasticity, and the case for tau-informed patient selection before amyloid immunotherapy

    ✓ Peer-reviewed Health systems and care delivery The journal of prevention of Alzheimer's disease

    Key finding: Amyloid immunotherapy with lecanemab and donanemab has been approved on the basis of statistically significant slowing of cognitive and functional decline in early Alzheimer's disease (1,2). +1 more finding

  11. 2026-08-13

    Predictive value of the Alzheimer polygenic risk score on cognitive decline in patients with mild cognitive impairment and Alzheimer's disease dementia

    ✓ Peer-reviewed Genetics The Journal of Prevention of Alzheimer s Disease

    Key finding: Higher AD-PRS was associated with faster CD in the full clinical cohort and in biomarker subset, independently of APOE genotype. +4 more findings

  12. 2026-08-12

    Effect of glycosylated hemoglobin on cognitive impairment related to White Matter Hyperintensity in non diabetes patients: A retrospective study

    ⚠ Preprint — not yet peer-reviewed Cognitive tests and assessment Research Square

    Key finding: HbA1c levels had warning value for cognitive impairment in non diabetes patients with WMH, and a nonlinear correlation exists between HbA1c and WMH-related cognitive impairment. +2 more findings

    Scored 29 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  13. 2026-08-12

    A Deep Learning-Derived Insulin Resistance Index for Cardiovascular Risk Prediction: A Prospective Cohort Study with External Validation in Chinese and US Populations

    ⚠ Preprint — not yet peer-reviewed How common it is medRxiv

    Key finding: The MoE-derived DNN-IR index demonstrated robust and stable performance in predicting atherosclerosis, incident CVD, cardiovascular mortality, and all-cause mortality in the general population. +2 more findings

    Scored 35 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  14. 2026-08-12
  15. 2026-08-12

    Effectiveness of Modern Diagnostic and Therapeutic Interventions for Major Neurological Disorders: A Systematic Literature Review

    ⚠ Preprint — not yet peer-reviewed Treatments Research Square

    Key finding: From 464 identified records, 30 peer-reviewed primary studies met all eligibility criteria following the exclusion of low-quality sources and unindexed preprints. +2 more findings

    Scored 50 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  16. 2026-08-12

    Prediction of mild cognitive impairment progression using time-sensitive multimodal biomarkers

    ✓ Peer-reviewed Mild cognitive impairment Science Advances

    Key finding: Plasma Aβ42/40, p-tau217, and tau PET each conferred higher risk, while hippocampal volume did not.

  17. 2026-08-12

    Effects of sexual differentiation and APOE genotype on the development of Alzheimer-related pathology in female EFAD mice

    ✓ Peer-reviewed Genetics Biology of Sex Differences

    Key finding: These findings suggest that sexual differentiation in early life has modest effects on adult development of AD in females, a relationship that appeared stronger in the context of APOE4 . +3 more findings

  18. 2026-08-12

    Prognostic significance of cerebrospinal fluid tau biomarkers in amyloid-negative A-T + N + neurodegeneration: A retrospective cohort study

    ✓ Peer-reviewed Tau biomarkers Journal of Alzheimer's disease : JAD

    Key finding: Survival was assessed using Kaplan-Meier analysis, and predictors of mortality were evaluated using Cox models. +3 more findings

  19. 2026-08-11

    Artificial intelligence education for health science and non-STEM students: a mixed- methods evaluation of an interdisciplinary mental health prototype development program

    ⚠ Preprint — not yet peer-reviewed Caregiving Research Square

    Key finding: This interdisciplinary, prototype-centered AI education program was associated with significant short-term improvements in students’ perceived AI knowledge, digital mental health readiness, interdisciplinary collaboration, innovation capacity, STEM career readiness, and solution-design ability. +3 more findings

    Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  20. 2026-08-11

    Active amyloid beta immunization ameliorates synapse loss and phosphorylated-tau accumulation around remaining plaques for up to 14 years after treatment

    ⚠ Preprint — not yet peer-reviewed Treatments medRxiv

    Key finding: Amyloid plaques, one of the defining features of Alzheimer’s disease, are associated with synapse loss and accumulation of pathological tau in dystrophic neurites and reactive glia in their immediate vicinity. +2 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  21. 2026-08-11

    Diagnostic Concordance Between Plasma p-Tau217 and Amyloid-β Biomarkers in Symptomatic Alzheimer's Disease: Evidence From a Chinese Cohort

    ⚠ Preprint — not yet peer-reviewed Biomarkers Research Square

    Key finding: Concordance between p-tau217 and Aβ was high in the AD and MCI groups (observed agreement 90.0% in each), but overall agreement across Cohort II was modest (166/351, 47.3%; Cohen's κ = 0.117, 95% CI 0.029–0.204). +2 more findings

    Scored 47 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  22. 2026-08-11

    Population-based reference equations and Z-scores for blood biomarkers of neurodegenerative diseases

    ⚠ Preprint — not yet peer-reviewed Tau biomarkers medRxiv

    Key finding: Blood biomarkers are increasingly used to support the diagnosis and monitoring of neurodegenerative diseases. +3 more findings

    Scored 34 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  23. 2026-08-10

    Differential associations of insulin resistance with anterior hippocampal volume in mild cognitive impairment and Alzheimer’s disease

    ⚠ Preprint — not yet peer-reviewed Cognitive tests and assessment bioRxiv

    Key finding: Insulin resistance is increasingly recognized as a metabolic factor associated with Alzheimer’s disease (AD); however, its relevance to hippocampal structural changes—a key pathological feature of AD—across disease stages is not fully understood. +3 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  24. 2026-08-10

    A Biologically Constrained Continuous-Time Framework for Long-Horizon Cognition Forecasting in Alzheimer’s Disease

    ⚠ Preprint — not yet peer-reviewed Cognitive tests and assessment medRxiv

    Key finding: These results demonstrate that embedding biological disease mechanisms within continuous-time deep learning improves the accuracy, biological plausibility, and clinical utility of long-horizon cognitive forecasting.

    Scored 47 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  25. 2026-08-10

    Association of age with clinical progression across plasma p-tau217 levels

    ⚠ Preprint — not yet peer-reviewed Cognitive tests and assessment medRxiv

    Key finding: STRUCTURED ABSTRACT BACKGROUND Chronological age and plasma p⍰tau217 each predicts cognitive decline, but whether their prognostic associations interact is unclear. +3 more findings

    Scored 50 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

Browse the library by subject, with the full score breakdown →